Vaccines aren’t yet available in South Africa, but government talks to finalize access are at an advanced stage and registration of the medicines will be fast-tracked.
Today, CFOs, CIOs and general counsels are facing a reality that demands the fusion of two crucial elements: visibility to maintain the smooth flow of the supply chain, and compliance with stringent regulations.
In the manufacturing of medical devices, there’s no margin of error. Does it make sense, then, to outsource production of those vital yet sensitive instruments?
Enhanced visibility, paired with purpose-built tools designed to monitor the organization’s most critical applications, along with a strategic response plan, can help manufacturers stay ahead of the curve.